These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24475020)

  • 1. Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP.
    Giannoni A; Baruah R; Leong T; Rehman MB; Pastormerlo LE; Harrell FE; Coats AJ; Francis DP
    PLoS One; 2014; 9(1):e81699. PubMed ID: 24475020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal-pro-Brain natriuretic peptide dynamics during effort phenotypes ischemic heart failure and determines prognosis regardless of ejection fraction.
    Popovic D; Djordjevic T; Jakovljevic D; Ristic A; Lasica R; Arena R; Guazzi M
    Peptides; 2020 Jul; 129():170315. PubMed ID: 32333999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ejection fraction, B-type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure.
    Greenberg B; Peterson ED; Berger JS; Laliberté F; Zhao Q; Germain G; Lejeune D; Wu JW; Lefebvre P; Fonarow GC
    Clin Cardiol; 2019 Feb; 42(2):277-284. PubMed ID: 30578576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure.
    Tasevska-Dinevska G; Kennedy LM; Cline-Iwarson A; Cline C; Erhardt L; Willenheimer R
    Int J Cardiol; 2011 Jun; 149(3):364-71. PubMed ID: 20202706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater prognostic value of peak VO2 after exercise training program completion in heart failure patients.
    Tabet JY; Meurin P; Benzidi Y; Beauvais F; Ben Driss A; Weber H; Renaud N; Dumaine R; Grosdemouge A; Cohen Solal A
    Int J Cardiol; 2013 Oct; 168(4):4139-44. PubMed ID: 23911267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Association Between Myocardial B-Type Natriuretic Peptide Release and Functional Capacity in Healthy Humans.
    Maeder MT; Thompson BR; Kaye DM
    Heart Lung Circ; 2018 Aug; 27(8):995-1003. PubMed ID: 28969979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing).
    Bensimhon DR; Leifer ES; Ellis SJ; Fleg JL; Keteyian SJ; Piña IL; Kitzman DW; McKelvie RS; Kraus WE; Forman DE; Kao AJ; Whellan DJ; O'Connor CM; Russell SD;
    Am J Cardiol; 2008 Sep; 102(6):712-7. PubMed ID: 18773994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Peak Oxygen Uptake in Patients Supported With Left Ventricular Assist Devices (PRO-VAD).
    Mirza KK; Szymanski MK; Schmidt T; de Jonge N; Brahmbhatt DH; Billia F; Hsu S; MacGowan GA; Jakovljevic DG; Agostoni P; Trombara F; Jorde U; Rochlani Y; Vandersmissen K; Reiss N; Russell SD; Meyns B; Gustafsson F;
    JACC Heart Fail; 2021 Oct; 9(10):758-767. PubMed ID: 34391745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
    van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
    J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation.
    Kato TS; Collado E; Khawaja T; Kawano Y; Kim M; Farr M; Mancini DM; Schulze PC
    Circ Heart Fail; 2013 Jan; 6(1):6-14. PubMed ID: 23204059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Peak Exercise Systolic Blood Pressure and Left Atrial Diameter as a Novel Non-Spirometry Prognostic Predictor Comparable to Peak Oxygen Uptake for Heart Failure With Reduced Ejection Fraction.
    Nakanishi M; Miura H; Nakao K; Fujino M; Arakawa T; Fukui S; Hasegawa T; Yanase M; Noguchi T; Goto Y; Yasuda S
    Circ J; 2019 Jun; 83(7):1528-1537. PubMed ID: 31142704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of Pretransplant Peak Oxygen Consumption to Outcomes After Heart Transplantation.
    Dhakal BP; Al-Kindi SG; Oliveira GH; ElAmm CA
    Am J Cardiol; 2020 Jul; 127():52-57. PubMed ID: 32471608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.
    Kitada S; Kikuchi S; Tsujino T; Masuyama T; Ohte N;
    ESC Heart Fail; 2018 Feb; 5(1):36-45. PubMed ID: 28941144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions.
    Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T;
    Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of peak oxygen consumption ≤ 10 ml/kg/min in heart failure: context vs. criteria.
    Corrà U; Giordano A; Mezzani A; Pistono M; Gnemmi M; Kamiya K; Giannuzzi P
    Int J Cardiol; 2013 Oct; 168(4):3419-23. PubMed ID: 23684598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction.
    Paul B; Soon KH; Dunne J; De Pasquale CG
    Heart Lung Circ; 2008 Dec; 17(6):497-501. PubMed ID: 18722158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.